Arrhythmias & electrophysiology

Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design

Am Heart JPublished Randomised controlled trial

Study context

Population
Patients ≥ 60 years with symptomatic ischemic stroke within the last 30 days, without known atrial fibrillation (AF) and without AF on an additional 24-hour Holter ECGplanned
Participants
5,200 patients
Planned comparison
Enhanced, prolonged and intensified ECG monitoring vs standard of care monitoring
Primary endpoint
Time until recurrent ischemic stroke or systemic embolism
Follow-up
At least 24 months
Methodological detailsrationale and design, open-label, parallel, multicentre, blinded endpoint assessment, 52 centres in Germany, 1:1 randomisation
  • Rationale and design
  • Open-label
  • Parallel
  • Multicentre
  • Blinded endpoint assessment
  • 52 centres in Germany
  • 1:1 randomisation

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design. Am Heart J. Published 7 July 2023. doi:10.1016/j.ahj.2023.06.016

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.